美国 · SEC FORM 4
Integer Holdings Corp
ITGR · NYSE · CIK 0001114483 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
18 同一窗口内观察到的 Form 4 交易行
3 sales · 15 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-12 · Harris John A.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 3,134,743
- 上期报告
- 2,569,857
- 日均成交量
- 886,754
- 回补天数
- 3.5
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | Harris John A | 买入 (P) | Common Stock | 1,650 | USD 70.00 | USD 115,500 | SEC 申报 ↗ |
| 2025-11-07 | Smith Diron | 买入 (P) | Common Stock | 1,116 | USD 67.19 | USD 74,973 | SEC 申报 ↗ |
| 2025-11-06 | Capps Cheryl C | 买入 (P) | Common Stock | 1,600 | USD 66.70 | USD 106,720 | SEC 申报 ↗ |
| 2025-10-30 | Khales Payman | 买入 (P) | Common Stock | 3,127 | USD 64.94 | USD 203,067 | SEC 申报 ↗ |
| 2022-12-16 | Dziedzic Joseph W | 买入 (P) | Common Stock | 4,000 | USD 61.95 | USD 247,800 | SEC 申报 ↗ |
| 2022-01-22 | Thomas Tommy P | 买入 (P) | Common Stock | 597 | USD 79.76 | USD 47,617 | SEC 申报 ↗ |
| 2020-11-05 | Dziedzic Joseph W | 买入 (P) | Common Stock | 5,000 | USD 58.12 | USD 290,600 | SEC 申报 ↗ |
| 2020-08-10 | Dziedzic Joseph W | 买入 (P) | Common Stock | 800 | USD 65.63 | USD 52,504 | SEC 申报 ↗ |
| 2020-08-07 | Dziedzic Joseph W | 买入 (P) | Common Stock | 2,400 | USD 64.67 | USD 155,208 | SEC 申报 ↗ |
Form 4 申报证据
86 transaction lines in the latest 365-day window; 586 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Thor Kirk K | 卖出 (S) | Common Stock | 11,767 | USD 126.23 | USD 1,485,348 | SEC 申报 ↗ |
| 2026-09-14 | Thor Kirk K | 卖出 (S) | Common Stock | 19,773 | USD 126.25 | USD 2,496,341 | SEC 申报 ↗ |
| 2026-09-08 | Senn Andrew | 卖出 (S) | Common Stock | 9,408 | USD 126.30 | USD 1,188,230 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Thor Kirk K | 卖出 (S) | Common Stock | 11,767 | USD 126.23 | USD 1,485,348 | SEC 申报 ↗ |
| 2026-09-14 | Thor Kirk K | 卖出 (S) | Common Stock | 19,773 | USD 126.25 | USD 2,496,341 | SEC 申报 ↗ |
| 2026-09-08 | Senn Andrew | 卖出 (S) | Common Stock | 9,408 | USD 126.30 | USD 1,188,230 | SEC 申报 ↗ |
| 2026-06-30 | Thor Kirk K | 期权行权/转换 (M) | Common Stock | 6,120 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-30 | Thor Kirk K | 代扣税 (F) | Common Stock | 2,409 | USD 93.45 | USD 225,121 | SEC 申报 ↗ |
| 2026-05-20 | PASSERINI FILIPPO | 奖励/授予 (A) | Common Stock | 1,967 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | MAXWELL MARTIN C | 奖励/授予 (A) | Common Stock | 1,967 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Kapito Aaron | 奖励/授予 (A) | Common Stock | 1,967 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Jeffers Alvin Tyrone | 奖励/授予 (A) | Common Stock | 1,967 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Flanagan James Francis | 奖励/授予 (A) | Common Stock | 1,967 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Capps Cheryl C | 奖励/授予 (A) | Common Stock | 1,967 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | COYLE MICHAEL J | 奖励/授予 (A) | Common Stock | 1,967 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Antrum Sheila | 奖励/授予 (A) | Common Stock | 1,967 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | Stephens Jim | 期权行权/转换 (M) | Common Stock | 1,963 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | Stephens Jim | 代扣税 (F) | Common Stock | 479 | USD 88.16 | USD 42,229 | SEC 申报 ↗ |
| 2026-05-08 | Smith Diron | 期权行权/转换 (M) | Common Stock | 2,063 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-08 | Smith Diron | 代扣税 (F) | Common Stock | 503 | USD 88.12 | USD 44,324 | SEC 申报 ↗ |
| 2026-03-24 | Carr Terence | 期权行权/转换 (M) | Common Stock | 1,350 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-24 | Carr Terence | 代扣税 (F) | Common Stock | 398 | USD 86.19 | USD 34,304 | SEC 申报 ↗ |
| 2026-03-24 | Blackwood Lindsay K. | 期权行权/转换 (M) | Common Stock | 3,483 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-24 | Blackwood Lindsay K. | 代扣税 (F) | Common Stock | 1,049 | USD 86.19 | USD 90,413 | SEC 申报 ↗ |
| 2026-03-13 | Thomas Tommy P | 卖出 (S) | Common Stock | 825 | USD 85.00 | USD 70,125 | SEC 申报 ↗ |
| 2026-03-12 | Kapito Aaron | 奖励/授予 (A) | Common Stock | 410 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-12 | Flanagan James Francis | 奖励/授予 (A) | Common Stock | 410 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-24 | Khales Payman | 期权行权/转换 (M) | Common Stock | 43,060 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-24 | Khales Payman | 代扣税 (F) | Common Stock | 16,945 | USD 87.10 | USD 1,475,910 | SEC 申报 ↗ |
| 2026-02-20 | Thor Kirk K | 代扣税 (F) | Common Stock | 2,198 | USD 84.85 | USD 186,500 | SEC 申报 ↗ |
| 2026-02-20 | Thor Kirk K | 奖励/授予 (A) | Common Stock | 9,025 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-20 | Thomas Tommy P | 代扣税 (F) | Common Stock | 713 | USD 84.85 | USD 60,498 | SEC 申报 ↗ |
| 2026-02-20 | Thomas Tommy P | 奖励/授予 (A) | Common Stock | 1,862 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ITGR |
| CIK | 0001114483 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3845 Electromedical & Electrotherapeutic Apparatus |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 586 transaction lines from 2020-01-03 to 2026-09-15 9 P purchase lines · 51 S sale lines · 526 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.